Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report

MLA

Shingo Kurahashi, et al. “Long-Term Follow-up after Rituximab plus Bendamustine in a Patient with Relapsed or Refractory Hairy Cell Leukemia Variant: A Case Report.” Medicine, vol. 100, no. 5, Oct. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c7009eff69316878908a6412b89fd809&authtype=sso&custid=ns315887.

APA

Shingo Kurahashi, Daisuke Koyama, Naoto Imoto, & Isamu Sugiura. (2020). Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report. Medicine, 100(5).

Chicago

Shingo Kurahashi, Daisuke Koyama, Naoto Imoto, and Isamu Sugiura. 2020. “Long-Term Follow-up after Rituximab plus Bendamustine in a Patient with Relapsed or Refractory Hairy Cell Leukemia Variant: A Case Report.” Medicine 100 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c7009eff69316878908a6412b89fd809&authtype=sso&custid=ns315887.